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Inhibition of glycosylhydrolases by peptides mimick-
ing carbohydrates opens a new field in antifungal re-
search.
The manuscript of Rao et al. [1] is a detailed study of
the interactions between two cyclopentapeptides, ar-
gifin and argafin, and a “bacterial” chitinase secreted
by the fungus Aspergillus fumigatus.
Chitin is one of the major structural components of
the cell wall of fungi and the exoskeleton of animals.
The presence of chitin in the extracellular matrix of
fungi is in total agreement with the animal origin of
fungi. Over time, enzymes associated with the synthe-
sis and remodeling of this polysaccharide have evolved
in number and complexity. Recent surveys of fungal ge-
nomes have shown that A. fumigatus, whose genome
is one of the most recently defined among the filamen-
tous fungi, has 8 chitin synthase and 18 chitinase genes
whereas only 3 and 2 respectively have been found in
yeasts.
At some point during their complex life cycle, such as
cytokinesis in yeast and conidial germination or hyphal
branching in molds, all pathogenic fungi have to hy-
drolyze chitin. Accordingly, chitinase was thought for a
long time to be an attractive antifungal target. Chitinase
inhibitors could have potential against pathogenic
fungi, but also against insects and parasites, since
these organisms have homologous chitinases. All puta-
tive inhibitors will be totally harmless to humans since
chitinases have no essential role for the human organ-
ism [2]. New antifungals targeted to cell wall are espe-
cially needed for fungi like A. fumigatus, that is to date
the most threatening air-borne pathogen in industrial-
ized countries and is responsible for numerous deaths
among immunocompromised patients. High mortality in
the hospital setting is due to lack of efficient antifungals
available to the clinician.
Chitinases are universal enzymes found in fungi, bac-
teria, parasites, plants, and insects. Two families of chi-
tinases (plant and bacteria) are distinguished based on
sequence homologies. These two families have the
same conserved block of amino acids containing in-
variant Asp and Glu residues (DXE motif) implicated in
the catalytic mechanism. In filamentous fungi, such as
Aspergillus and Coccidioides species, “bacterial“ chi-
tinases have deduced molecular masses of approxi-
mately 46–48 kDa, are secreted, and do not have po-
tential 0-glycosylation sites [3]. They are responsible for
the digestion and utilization of exogenous chitin as a
source of organic nutrients for energy and biosynthesis
[4]. Accordingly, disruption of the A. fumigatus ChiB1,
encoding the chitinase, analyzed in the study of Rao et
al. [1], had no effect on growth or morphogenesis of
the organism. The “plant“ chitinases of Aspergillus and
Coccidioides species have an apparent MW higher than
enzymes of the bacterial class (deduced molecular
mass 83–97 kDa). Further, the plant chitinase family
contains a serine-threonine-rich domain, suggesting
potential sites of 0-mannosylation as shown in S. cere-
visiae [3]. This domain is followed by a cysteine-rich,high-affinity chitin binding region [4]. Five homologs of
the plant chitinases have been identified in A. fumiga-
tus. Only one member of this family has a putative GPI
anchor and associated cleavage site (http://www.tigr.
org/tdb/e2k1/afu1/), suggesting that this enzyme may
function in morphogenesis since most of the GPI an-
chored proteins of A. fumigatus have a putative role in
cell wall construction [5]. Disruption of the ortholog of
this gene in A. nidulans leads indeed to a decrease in
the frequency of spore germination and a lower rate of
hyphal formation [6]. In A. fumigatus, the role of the four
other plant chitinases will await the disruption of their
encoding genes [4]. Although analyzing the interactions
of inhibitor peptides with a chitinase that have a role in
morphogenesis would have been more appropriate in
the study of Rao et al., the results obtained with ChiB1
should be easily compared with plant chitinases. The
3D structure has been determined for various chi-
tinases [7]; data of all families substantiate the strict
conservation of the catalytic machinery, show the cleft
structure in the active site, and show that substrate de-
gradation occurs with retention of the configuration at
the anomeric carbon. Sequence similarities are also
confirmed biologically since anti-human chitinase anti-
bodies have been shown by immunofluorescence
studies to label the tip of A. fumigatus conidial germ
tubes (J.-P. Latgé, unpublished data).
The two cyclopentapeptides described by Rao et al.
[1] not only mimic the carbohydrate substrate of the
glycosylhydrolase but also inhibit the activity because
of their binding capacity to the catalytic site. The con-
cept of using peptides that mimic carbohydrates to
fight microorganisms emerged in the 1990s. While car-
bohydrates are critical molecules in the interaction be-
tween microbes and host cells, they are not readily
studied molecularly using genetic vectors and are poor
immunogens. Therefore, the use of peptides (easy to
produce, characterize, and manipulate) as substitutes
for natural polysaccharides has been developed. To
date, most studies in this area are focused on vaccina-
tion and immunodiagnosis. For example, in Mycobac-
terium tuberculosis, peptides which mimic the oligo-
mannosidic motifs shared by the bacterial cell envelope
are now exploited in the generation of immune re-
sponses against Mycobacterium, broadening the op-
tions for vaccine development against tuberculosis [8].
Similarly, in the fungus Cryptococcus neoformans, a
peptide mimetic of the capsular polysaccharide glucur-
onoxylomannan induces a protective response against
this fungus [9]. In the MethA tumor, a peptide mimetic
of the 0-b linked N-acetylglucosamine present on the
tumor surface-expressed glycoproteins stimulates the
regression of the tumor via the activation of specific
antitumor cellular responses [10].
Besides argifin and argafin cyclopentapeptides, only
two other reports exist in the literature on the role of
peptides that block protein activity because they are
recognized by the carbohydrate binding site of this pro-
tein. The first study concerns peptides mimicking the
β-galactose N-terminal moiety of glycosphingolipids
which have important roles in cell recognition by viruses
and microorganisms [11]. This peptide, potentially in-
teresting for vaccination, has also a physiological activ-
ity since it has a potent inhibitory effect on β-galactosi-
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8dase, thus indicating that it may act specifically on the i
tenzymes. The other study comes from the research
group of van Aalten, which investigated the inhibition
of another bacterial chitinase by a cyclic dipeptide A
Acalled CI-4 [12]. However, until now, the mechanism of
interaction between the peptide-mimicking carbohy- I
Pdrates and the protein, and its binding site, was un-
Fknown; the structure of the complexes between chi-
tinase and the cyclic peptide presented by Rao et al.
[1] give several hints on how to increase the affinity of
Sthe peptides for the family 18 chitinase and how to
modify, for example, the side chains to increase the effi-
ciency of the inhibitor. Concurrent analysis of the data
presented by Rao et al., and another prominent study
of a peptide binding to the a mannopyranoside site of
ConA, showed related types of hydrogen bonds and
hydrophobic interactions during the replacement of a
carbohydrate by a peptide [13].
In conclusion, a new development of carbohydrate
minotopes is seen through this study. Screening of nat-
ural peptides or peptide libraries, chemically synthe-
sized or obtained by phage display, could lead to the
identification of new, simple inhibitors with known in-
teractions. The manuscript of Rao et al. is a landmark
in this area. It provides not only a way to analyze in-
teractions and modify chemically the cyclopeptide in-
hibitors to obtain species-specific inhibitor but also 1
opens new research avenues for nonsugar derivatives
to inhibit glycosylhydrolases. The results also suggest
1a potential for peptides to inhibit other cell wall en-
zymes in addition to the chitinases. For example, echi-
1
nocandins are cyclohexapeptides that inhibit fungal
β1,3 glucan synthases. Based on the results of Rao et 1
al., the use of peptides that mimic carbohydrates tonhibit glycosylhydrolases should become prominent in
he near future.
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